Production problems have caused makers of the promising new Fuzeon-like fusion inhibitor T-1249 t
Production problems have caused makers of the promising new Fuzeon-like fusion inhibitor T-1249 to stop clinical trials.
Outside the walls and on the Web, find a helpful list of resources on HIV in prison at www.atac-usa.org/Prisons.html.
A German study found that treatment with HAART reduced liver-related deaths among HIVers coinfected with hep C.
83 new HIV-related meds are now in pharma trials—to add to the 80 already approved—says a drugmakers’ association.
Metformin, a med for diabetes and related conditions common to HIVers, is safer than docs had thought, new research shows.
www.women-alive.org offers women HIVers a new service: Ask Debbie (DearDebbie@women-alive.org), for treatment advice.